Nektar Therapeutics
Delayed Nasdaq - 07/20 10:00:00 pm
48.73USD
-0.71%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Researches and develops inhalation drug delivery systems

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms.

It operates through the United States and Europe geogrpahical segments.

The company was founded in 1990 and is headquartered in San Francisco, CA.
Managers
Name Title
Howard W. Robin President, Chief Executive Officer & Director
Robert B. Chess Chairman
John Nicholson Chief Operating Officer & Senior Vice President
Gilbert M. Labrucherie Chief Financial Officer & Senior Vice President
Stephen K. Doberstein Chief Research & Development Officer, Senior R&D
Mary Tagliaferri Chief Medical Officer & SVP-Clinical Development
Jonathan Zalevsky Chief Scientific Officer & Senior VP-Research
Christopher A. Kuebler Independent Director
Roy A. Whitfield Independent Director
Lutz Lingnau Independent Director
Shareholders
Name Equities %
Fidelity Management & Research Co. 24,854,035 14.5%
PRIMECAP Management Co. 20,902,922 12.2%
The Vanguard Group, Inc. 18,020,538 10.5%
OppenheimerFunds, Inc. 11,560,779 6.74%
BlackRock Fund Advisors 9,716,962 5.67%
Wellington Management Co. LLP 6,819,244 3.98%
SSgA Funds Management, Inc. 6,003,908 3.50%
Henderson Global Investors Ltd. 4,895,968 2.86%
Norges Bank Investment Management 2,424,788 1.41%
Camber Capital Management LLC 2,000,000 1.17%
Company contact information
Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco, CA 94158

Phone : +1.415.482.5300
Fax : +1.415.339.5300
Web : www.nektar.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capi. (M$)
NEKTAR THERAPEUTICS-18.40%10 289
CELLTRION, INC.--.--%29 483
IQVIA HOLDINGS INC22.86%24 367
LONZA GROUP17.93%23 220
INCYTE CORPORATION-27.36%14 625
SEATTLE GENETICS, INC.39.51%11 852
NEKTAR THERAPEUTICS0.52%10 289
ALNYLAM PHARMACEUTICALS, INC.-25.56%9 521
QIAGEN20.53%8 605
ICON PLC28.11%7 806
SAGE THERAPEUTICS INC-7.67%7 097
IONIS PHARMACEUTICALS INC1.07%6 979
ALKERMES PLC-18.64%6 916
BIO-TECHNE CORP39.33%6 782
PRA HEALTH SCIENCES INC11.65%6 545
EXACT SCIENCES CORPORATION-7.04%5 995
CHARLES RIVER LABORATORIES INTL. INC10.67%5 804
UNITED THERAPEUTICS CORPORATION-15.10%5 472
LIGAND PHARMACEUTICALS INC.81.10%5 233
GALAPAGOS12.33%5 209
GALAPAGOS NV (ADR)8.08%5 209